Comparing the effectiveness of steroid delivered via a nebuliser or a sinus rinse in the management of chronic rhinosinusitis.
Phase 1
- Conditions
- Chronic rhinosinusitisInflammatory and Immune System - Other inflammatory or immune system disordersRespiratory - Other respiratory disorders / diseasesSurgery - Other surgeryInfection - Other infectious diseases
- Registration Number
- ACTRN12620000578909
- Lead Sponsor
- Professor Peter-John Wormald
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Participants must have had at least two of the following symptoms of chronic rhinosinusitis (nasal discharge, postnasal drip, nasal obstruction, facial pain and pressure or lack of sense of smell) that has been previously persistent for greater than 3 months.
- Participants must have had at least one operation for their chronic rhinosinusitis but should be at least 6 weeks post-operative.
- Participants must show evidence of chronic rhinosinusitis by direct endoscopic examination.
Exclusion Criteria
- Age under 18
- Participants unable to give informed written consent
- Participants unable to comply with study protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method